Hematopoetic progenitor cells, cord blood (Hemacord)

From HemOnc.org - A Hematology Oncology Wiki
Jump to: navigation, search

FDA approved 11/10/2011

General information

Class/mechanism: Hematopoietic stem/progenitor cells isolated from cord blood; hematopoetic progenitor cells, cord blood (HPC-C) migrate to the bone marrow, engraft, divide, and produce mature blood cells. For use in unrelated donor hematopoietic progenitor cell transplantation.[1][2]
Route: IV
Extravasation: No information

For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]

Patient drug information

No information available.

Also known as

  • Brand name: Hemacord


  1. 1.0 1.1 Hematopoetic progenitor cells, cord blood (Hemacord) package insert
  2. Hematopoetic progenitor cells, cord blood (Hemacord) package insert (locally hosted backup)